Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat Mu Opioid Receptor ELISA Kit (AC3276)
Cat.#: ASET-1865
Specifications
Description Rat Mu Opioid Receptor ELISA Kit allows for the in vitro quantitative determination of rat Mu Opioid Receptor concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 18.75 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 31.25-2000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-1339 Human YWHAE ELISA Kit (AC2750) Quantitative inquiry ASET-1802 Human TMEM158 ELISA Kit (AC3213) Quantitative inquiry ASET-2277 Human DUOX2 ELISA Kit (AC3688) Quantitative inquiry ASET-1141 Human Dio3 ELISA Kit (AC2552) Quantitative inquiry ASET-1085 Sheep Leptin ELISA Kit (AC2496) Quantitative inquiry ASET-1738 Mouse Progesterone Receptor ELISA Kit (AC3149) Quantitative inquiry ASET-1465 Human Meteorin ELISA Kit (AC2876) Quantitative inquiry ASET-1309 Human Plasminogen Activator ELISA Kit (AC2720) Quantitative inquiry ASET-1668 Rat SIRP alpha ELISA Kit (AC3079) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket